Pearton et al., 2013 - Google Patents
Host responses in human skin after conventional intradermal injection or microneedle administration of virus‐like‐particle influenza vaccinePearton et al., 2013
View HTML- Document ID
- 1160976585933048406
- Author
- Pearton M
- Pirri D
- Kang S
- Compans R
- Birchall J
- Publication year
- Publication venue
- Advanced healthcare materials
External Links
Snippet
Miniaturized microneedle devices are being developed for painlessly targeting vaccines to the immune cell populations in skin. As skin immunization studies are generally restricted to animal models however, where skin architecture and immunity is greatly different to human …
- 210000003491 Skin 0 title abstract description 86
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pearton et al. | Host responses in human skin after conventional intradermal injection or microneedle administration of virus‐like‐particle influenza vaccine | |
| Prow et al. | Nanopatch‐targeted skin vaccination against West Nile virus and chikungunya virus in mice | |
| Fernando et al. | Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model | |
| Mandal et al. | Cell and fluid sampling microneedle patches for monitoring skin-resident immunity | |
| Kenney et al. | Dose sparing with intradermal injection of influenza vaccine | |
| Chen et al. | Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization | |
| Amundson et al. | Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation | |
| Choi et al. | Live vaccinia virus-coated microneedle array patches for smallpox vaccination and stockpiling | |
| Gill et al. | Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine | |
| del Pilar Martin et al. | Local response to microneedle-based influenza immunization in the skin | |
| Foley et al. | Virulent systemic feline calicivirus infection: local cytokine modulation and contribution of viral mutants | |
| Chen et al. | Site‐Selectively Coated, Densely‐Packed Microprojection array patches for targeted delivery of vaccines to skin | |
| Verdijk et al. | Maximizing dendritic cell migration in cancer immunotherapy | |
| Lee et al. | A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice | |
| Rotrosen et al. | Assessing the generation of tissue resident memory T cells by vaccines | |
| Wang | MicroRNAs, Parkinson’s disease, and diabetes mellitus | |
| Vatu et al. | Assessment of efficacy of dendritic cell therapy and viral therapy in high grade glioma clinical trials. A meta-analytic review | |
| Choi et al. | Sequential transcriptome changes in the penumbra after ischemic stroke | |
| Shaddel et al. | Cryotherapy of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice: A comparative experimental study | |
| Patterson et al. | Granulomatous inflammation in Tuberculosis and Sarcoidosis: Does the lymphatic system contribute to disease? | |
| Kouiavskaia et al. | Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study | |
| Ito et al. | Characteristic of K3 (CpG-ODN) as a transcutaneous vaccine formulation adjuvant | |
| Patel et al. | Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes | |
| Files et al. | Self-adjuvanting nanovaccines boost lung-resident CD4+ T cell immune responses in BCG-primed mice | |
| Depelsenaire et al. | Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial |